Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy and monoclonal antibody therapy before a donor stem cell
transplant helps stop the growth of cancer cells. It also helps stop the patient's immune
system from rejecting the donor's stem cells. When the healthy stem cells from a donor are
infused into the patient they may help the patient's bone marrow make stem cells, red blood
cells, white blood cells, and platelets.
PURPOSE: This phase II trial is studying donor stem cell transplant in treating patients with
mantle cell lymphoma.